AUPH financials
Aurinia Pharmaceuticals (AUPH) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
AUPH income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $283.06M | $250.39M | $104.91M | $287.20M | 2.07 |
| 2024 | $235.13M | $206.88M | -$4.69M | $5.75M | 0.04 |
| 2023 | $175.51M | $161.37M | -$91.69M | -$78.02M | -0.54 |
| 2022 | $134.03M | $128.37M | -$111.47M | -$108.18M | -0.76 |
| 2021 | $45.60M | $44.51M | -$180.74M | -$180.97M | -1.40 |
| 2020 | $50.12M | $50.12M | -$104.29M | -$102.68M | -0.87 |
- AUPH revenue was $283.06M in fiscal 2025, net income $287.20M.
Updated 2026-11-04 03:58 UTC